Mary Caffrey

Articles

NCCN Expands Guidelines for Colorectal Cancer Treatment

March 25, 2019

Wells A. Messersmith, MD, co-director of the developmental therapeutics program at the University of Colorado Cancer Center, said work in this area is needed to fill the knowledge gaps in metastatic CRC, which has a 5-year survival rate of just 11%.

More Hospice Care Meant Longer Survival, Lower End-of-Life Costs for Metastatic Melanoma Patients

June 04, 2014

A study of patients with metastatic melanoma found that those who spent more time in hospice care lived almost four months longer than similar patients who had little or no hospice care, and that end-of-life costs dropped for those with more time in hospice.